Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Mid Investment Style: Growth |
| Morningstar category | Health |
| Launch date | 01 May 2002 |
| Price currency | USD |
| Domicile | United States |
| Symbol | AHSAX |
| Manager & start date | Daniel Chung 01 Oct 2005 Sanjiv Talwar 01 Jul 2021 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | 117.28m USD As of Mar 31 2024 |
| Share class size | 72.85m USD As of Mar 31 2024 |
| Net expense ratio | 1.13% |
| Front end load | 5.25% |
| Deferred load | -- |
| Maximum Redemption Fee | -- |
| Min. initial investment | 1,000.00 USD |
| Min. additional investment | 50.00 USD |
| Initial IRA | 500.00 USD |
| Additional IRA | 50.00 USD |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 41.04% | 26.26% | 0.00% | 26.26% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Amgen Inc AMGN:NSQ | +9.23% | 5.49% | |
| Vertex Pharmaceuticals Inc VRTX:NSQ | +20.04% | 5.29% | |
| Regeneron Pharmaceuticals Inc REGN:NSQ | +10.87% | 5.21% | |
| Stryker Corp SYK:NYQ | +8.73% | 5.19% | |
| Eli Lilly and Co LLY:NYQ | +96.05% | 5.08% | |
| Per cent of portfolio in top 5 holdings: 26.26% |
Asset type
| US stock | 83.76% |
| Non-US stock | 8.87% |
| Cash | 1.29% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Other | 6.09% |
Top 5 sectors
| Healthcare | 92.62% |
Top 5 regions
| United States | 83.76% |
| Europe - ex Euro | 5.99% |
| United Kingdom | 1.98% |
| Eurozone | 0.89% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
